www.fdanews.com/articles/122172-lexicon-says-ibs-drug-met-mid-stage-study-goal

Lexicon Says IBS Drug Met Mid-Stage Study Goal

November 13, 2009

Lexicon Pharmaceuticals Inc. said an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial.
Yahoo! Finance